Targeting PAX7 and IL-6 in senescent muscle and oculopharyngeal muscular dystrophy (OPMD), a condition analogous to senescent muscle, leads to diminished muscle regeneration and functional decline. Here, PAX7 is linked to oculopharyngeal muscular dystrophy.